文献速递医院感染防控细菌感染、耐药与抗菌药物

日本、泰国与美国医院感染预防实践:全国性调查结果

Infection Prevention Practices in Japan, Thailand, and the United States: Results From National Surveys.
PubMed 文献 · Clin Infect Dis · 2017-01-01

该研究比较了日本(2012年)、美国(2013年)和泰国(2014年)的医院调查数据,评估预防中央导管相关血流感染(CLABSI)、呼吸机相关肺炎(VAP)和导管相关尿路感染(CAUTI)推荐实践的常规使用情况。结果显示,三国多数医院已采用部分CLABSI和VAP预防措施,但CAUTI预防实践使用差异较大,且仅少数实践被超过50%的医院采用。

要点

  • 三国多数医院常规使用最大无菌屏障预防CLABSI,美国使用率最高。
  • 半卧位预防VAP在泰国和美国使用率很高,日本相对较低。
  • CAUTI预防实践在三国使用差异大,仅少数实践被超过50%医院采用。

核心结论

  • 日本、泰国和美国多数医院已采用部分CLABSI和VAP预防实践,但三国均存在改进感染预防活动的机会。

研究设计与样本

  • 研究评估了日本(2012年)、美国(2013年)和泰国(2014年)的医院调查数据,比较推荐感染预防实践的常规使用情况。
  • 调查应答率在日本和美国均为71%,在泰国为87%。

主要发现

  • 使用最大无菌屏障预防CLABSI的医院比例:日本76.6%、泰国63.2%、美国97.8%。
  • 使用半卧位预防VAP的医院比例:日本66.2%、泰国86.7%、美国98.7%。
  • 泰国和美国近全部医院(>90%)报告监测CLABSI、VAP和CAUTI率,日本仅多数医院监测CLABSI率。
  • CAUTI预防实践的常规使用在三国间存在差异,仅少数实践被>50%的医院采用。

临床怎么用

  • 提示三国应针对各自薄弱环节加强感染预防实践,尤其需提升CAUTI预防措施和日本监测实践的覆盖率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Numerous evidence-based practices for preventing device-associated infections are available, yet the extent to which these practices are regularly used in acute care hospitals across different countries has not been compared, to our knowledge. METHODS: Data from hospital surveys conducted in Japan, the United States, and Thailand in 2012, 2013, and 2014, respectively, were evaluated to determine the use of recommended practices to prevent central line-associated bloodstream infection (CLABSI), ventilator-associated pneumonia (VAP), and catheter-associated urinary tract infection (CAUTI). The outcomes were the percentage of hospitals reporting regular use (a score of 4 or 5 on a scale from 1 [never use] to 5 [always use]) of each practice across countries and identified hospital characteristics associated with the use of selected practices in each country. RESULTS: Survey response rates were 71% in Japan and the United States and 87% in Thailand. A majority of hospitals in Japan (76.6%), Thailand (63.2%), and the United States (97.8%) used maximum barrier precautions for preventing CLABSI and semirecumbent positioning to prevent VAP (66.2% for Japan, 86.7% for Thailand, and 98.7% for the United States). Nearly all hospitals (>90%) in Thailand and the United States reported monitoring CLABSI, VAP, and CAUTI rates, whereas in Japan only CLABSI rates were monitored by a majority of hospitals. Regular use of CAUTI prevention practices was variable across the 3 countries, with only a few practices adopted by >50% of hospitals. CONCLUSIONS: A majority of hospitals in Japan, Thailand, and the United States have adopted certain practices to prevent CLABSI and VAP. Opportunities for targeting prevention activities and reducing device-associated infection risk in hospitals exist across all 3 countries.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Krein SL, Greene MT, Apisarnthanarak A, et al. Infection Prevention Practices in Japan, Thailand, and the United States: Results From National Surveys. Clin Infect Dis. 2017. PMID: 28475786. doi:10.1093/cid/cix073

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。